Introduction
Acorus tatarinowii has been historically used as a principal medicine in traditional Chinese formulas for the treatment of learning and memory disorders, dementia and dysmnesia.
1,2 Previous studies on Acorus tatarinowii have revealed that the most notable constituents are a-and b-asarones, which exhibit a wide spectrum of biological activities, such as cerebrovascular protection, anticancer, antioxidation, neuroprotection, anti-neuroinammation, improving cognitive function, antidepressant-like effects and antibacterial activity.
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Over the course of our continuing investigations on bioactive asarone analogues from the rhizomes of Acorus tatarinowii, 14 neolignans (1-7, 9-15), one quinone (8) , six asarone analogues (16) (17) (18) (19) (20) (21) , along with a-and b-asarones (22 and 23) were isolated. Interestingly, compounds 1-3 were obtained as stereoisomers, represented the rst examples of naturally occurring 7-O-7 0 type neolignans. meso-Asarolignan A (1) was dened as a mesomer, while (AE)-asarolignan B (2) and C (3) were two pairs of 7-O-7 0 neolignan enantiomers. The resolution of enantiomers 2 and 3 by chiral HPLC led to the isolation of 2a/2b and 3a/3b.
Considering the racemic nature of the compounds from this plant, compounds 3-8 were also determined as racemic mixtures due to their negligible optical activities. In addition, all isolated compounds were assayed for their antineuroinammatory effects on tumor necrosis factor a (TNF-a) production in the murine microglia BV-2 cells.
Results and discussion
Compound 1 was obtained as colourless block crystal. Its molecular formula was determined to be C 24 C NMR in combination with DEPT135 experiments resolved 12 carbon signals, corresponding to six aromatic carbons, two oxygenated methine carbons, one methyl, and three methoxy groups. These data together with the molecular formula could make us assume that 1 might be a highly symmetrical structure. Further analysis of the 1 H-1 H COSY, HSQC and HMBC spectra allowed the establishment of the partial C 6 -C 3 moiety (1 0 ,2 0 -dihydroxyasarone moiety, half of the structure) in compound 1 (Fig. 4) . The large coupling constant between H-7 (H-7 0 ) and H-8 (H-8 0 ) (J ¼ 7.9 Hz) indicated a threo relative conguration. Connection of the two C 6 -C 3 units in 1 was mainly carried out by using the results of HMBC and X-ray analyses. The key HMBC correlations from H-7 to C-7 0 or H-7 0 to C-7 indicated the linkage of the two C 6 -C 3 units through C-7-O-C-7 0 bonds. The fact that compound 1 bears four chiral centres and symmetric nature, was undoubtedly conrmed by X-ray ( Fig. 2 ) using anomalous scattering of Mo Ka radiation. The crystals of 1 belong to monoclinic space group P2 1 /c, showing a helical conformation with an intramolecular mirror symmetry. These ndings, combined with the lack of optical activity supported that compound 1 was obtained as a mesomer. Therefore, the structure of 1 was established as a novel 7-O-7 0 neolignan mesomer, and named meso-asarolignan A. Fig. 4 ) with a threo relative conguration was assigned in 2. Crystals of 2 were obtained from CH 3 OH-H 2 O (9 : 1), which allowed the establishment of the structure of 2 by X-ray analysis (Fig. 2) . Thus, 2 was unambiguously dened as a stereoisomer of 1. The chiral HPLC and optical rotation data indicated that 2 was racemic mixture. Subsequent chiral resolution of 2 by HPLC yielded the enantiomers 2a and 2b in a 1 : 1 ratio. The enantiomers displayed typical antipodal ECD curves ( Fig. 3) Fig. 1 . Similarly, the enantiomers (+)-3a and (À)-3b were obtained and showed opposite ECD curves and optical rotations of opposite sign. Comparing the CD spectra of 2 (a/b) and 3 (a/b) in Fig. 3 arising from two C 3 substructures (C-7-C-8-C-9 and C-7 0 -C-8 0 -C-9 0 ) shown in bold lines in Fig. 4 . In the HMBC spectrum,
correlations from H-6 to C-7, H-7 to C-1/C-2/C-6, H-6 0 to C-7 0 , and H-8 0 a to C-1 0 , allowed the establishment of two C 6 -C 3 units. together with the key HMBC correlations from Me-9 to C-7/C-7 0 , and H-8 to C-1 0 /C-8 0 , indicated the two C 6 -C 3 units were connected via C-8-C-7 0 bond form a neolignan (Fig. 4) . A methoxy group at d H 2.99 was located at C-7 as conrmed by the HMBC correlation from MeO-7 to C-7. The remaining six methoxy resonances were unambiguously located on the aromatic rings C NMR data for compounds 1-3 by using the HMBC and NOE experiments. Finally, an X-ray diffraction analysis was performed, from which the relative conguration of 4 (7S*,8 0 R*,7 0 R*) was determined ( (Table 2 ) indicated its structural similarity to 4, except for the replacement of a methine and a methylene groups by two olenic carbons. By 1 H-1 H COSY, HSQC, and HMBC spectra, two C 6 -C 3 units were assigned as shown in Fig. 4 . Similarly, the connection between C-8 and C-9 0 was determined as the correlations from Me-9 to C-7/C-9 0 , H-7 to C-9 0 , and H-9 0 to C-8/C-9/C- Fig. 6 ), and the HMBC correlations of H-7 to C-1/C-2/C-6/C-8 0 , and H-7 0 to C- 9 and MeO-7, H-8 and H-7 0 , as well as Me-9 0 and H-7 0 suggested that H-7, H-8 and H-7 0 were b-oriented, whereas H-8 0 was situated on the opposite side. Considering the racemic nature, chiral HPLC analysis was performed and the resolved enantiomers (7a and 7b) possessed the opposite CD curves (Fig. 7) . The 16, 17 (7S*,8S*)-7,8-dihydroxyasarone (17), 16, 17 (7R*,8S*)-(7-methoxy-8-hydroxy)-asarone (18), 16, 17 (7S*,8S*)-(7- No. 19 were identied by comparison of their physiochemical properties and spectral data with those reported in the literature. Among them, the known compound (AE)-acortatarinowin H (8) was obtained as red-brown block crystals, the X-ray diffraction experiment showed an unambiguous assignment of the congurations as 7 0 S*,8 0 R* (Fig. 5) . It was worth noting that the crystals of 8 had a P2 1 /n space group, indicating a racemic nature, which was in accordance with its small optical value {[a] 23 D 0 (c 0.5, MeOH)}. Subsequent chiral resolution was performed on a chiral column to yield 8a and 8b, which were opposite in terms of ECD curves (see ESI †). The absolute congurations of 8a and 8b were determined as (7 0 S,8 0 R) and (7 0 R,8 0 S), respectively, by comparing their cotton effects at 280-300 nm in CD spectra with those reported in the literatures.
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Tatarinoid C (14) was rstly separated by chiral HPLC analysis. Compared with calculated ECD spectra of (8R)-14, the two enantiomers named as (+)-tatarinoid C (14a) and (À)-tatarinoid C (14b), respectively (see ESI †). Pharmacological studies have indicated that neuroinammation plays a major role such as dysregulation of genes in the pathophysiology of Alzheimer's disease (AD) and Parkinson's disease (PD).
22 TNF-a is one of the critical proinammatory cytokines. 23, 24 To a certain extent, reducing TNFa levels has the potential to medicate anti-neuroinammation action. In our study, all the isolated compounds were evaluated for anti-neuroinammatory activities on TNF-a production in LPS-activated BV-2 cells. As shown in Fig. 8, compounds 7a,   7b, 14a, 14b, 16, 20 , and 22 could reduce TNF-a levels in the murine microglia BV-2 cells. A comparison of the inhibition of the enantiomers 7 (7a/7b), and 14 (14a/14b) in this assay, suggested the conguration was not critical to the antineuroinammation activity. In addition, all the compounds were assayed for cytotoxicity against BV-2 cells by CCK-8 method, and a-asarone (23) displayed cytotoxicity at 20 and 50 mM.
Conclusions
In summary, twenty-three compounds derived from asarone biogenetic pathway were isolated and identied from the rhizomes of Acorus tatarinowii, including seven new neolignans (1-7). Their structures including absolute congurations were determined by comprehensive spectroscopic data together with X-ray crystallography, as well as experimental and calculated ECD spectra. Besides, all the compounds were evaluated for anti-neuroinammatory activities on TNF-a production in LPSactivated BV-2 cells. INDO (indomethacin, 10 mM) and DEX (dexamethasone, 10 mM) were used as positive control. As results, compounds 7, 7a, 7b, 14b and 16 exhibited obvious inhibitory effects on the release of TNF-a at a concentration of 50 mM, their TNF-a level were 1.7, 2.0, 1.9, 2.5 and 2.6 mg mL À1 , respectively; compound 20 could inhibit the release of TNF-a at a concentration of 20 mM (TNF-a level was 2.5 mg mL À1 ) and 50 mM (TNF-a level was 2.1 mg mL À1 ); compound 22 could dramatically reduce TNF-a level at a concentration of 5 mM (TNF-a level was 2.8 mg mL À1 ) and 50 mM (TNF-a level was 2.6 mg mL À1 ). These ndings will provide some scientic foundation for the utilization of Acorus tatarinowii as CNS disorders treatment.
Experimental

General experimental procedures
Optical rotations were measured on a JASCO P-1020 polarimeter with a 1 cm cell at room temperature. UV spectra were recorded on a JASCO V-550 UV/Vis spectrometer. IR spectra were obtained using a JASCO FT/IR-480 plus spectrometer. CD spectra were obtained on a JASCO J-810 spectropolarimeter at room p < 0.01, when compared to the control + DMSO group, and *P < 0.05, **P < 0.01, ***P < 0.001, when compared to the LPS + DMSO group. temperature. HRESIMS spectra were acquired using a Waters Synapt G2 mass spectrometer. 1D and 2D NMR data were acquired with Bruker AV 600, and AV 400 using solvent signals ( 
Plant material
The dried rhizomes of Acorus tatarinowii were purchased from PuraPharm Corporation in 2011 and identied by Jia-Fu Wei, the pharmacist of Guangxi Institute for Food and Drug Control, China. A voucher specimen (20110301) was deposited in the Institute of Traditional Chinese Medicine & Natural Products, Jinan University, Guangzhou, P. R. China.
Extraction and isolation
The air-dried and powdered rhizomes of Acorus tatarinowii (19.5 kg) were reuxed with 60% EtOH for 2 h (Â2) to give an crude extract (2.2 kg), which was suspended in water (10 L) followed by an exhaustive partition with EtOAc and n-BuOH. The EtOAc soluble extract (312.0 g) was separated by silica gel CC (f 12.0 Â 36.0 cm) eluted with gradient cyclohexane-EtOAc (100 : 0 / 0 : 100) to afford seven fractions (Fr. 1-7). Fr. 2 (144.9 g) was fractionated further by silica gel CC (f 2. 8 g ) was separated by silica gel CC (f 3.5 Â 57.0 cm) eluted gradiently with CHCl 3 -acetone followed data for structure 4 has been deposited at the Cambridge Crystallographic Data Centre (CCDC 1518427). † Crystal data for compound (8 ]. The structure was solved by direct methods using the SHELXS-97 program, and rened by the program SHELXL-97 and full-matrix least-squares calculations. In the structure renements, nonhydrogen atoms were placed on the geometrically ideal positions by the "ride on" method. Hydrogen atoms bonded to oxygen were located by the structure factors with isotropic temperature factors. The nal renement gave R ¼ 0.0382, R w ¼ 0.1016, S ¼ 1.055. Crystallographic data for structure 8 has been deposited at the Cambridge Crystallographic Data Centre (CCDC 1518428). †
ECD calculation method
In theoretical calculations, the geometry of the molecules was optimized with Gaussian 09 package 33 at B3LYP/6-31G(d) computational level. The minimum nature of the structure was conrmed by frequency calculations at the same computational level. Then ECD calculations were carried out in the methyl cyanide solvent medium using time-dependent density functional theory (TDDFT) with B3LYP functional and DGDZVP basis set.
Anti-neuroinammatory activity assays
BV-2 cells were obtained from Peking Union Medical College (PUMC) Cell Bank (Beijing, People's Republic of China) and were maintained at 5 Â 10 5 cells per mL in DMEM medium supplemented with 10% heat-inactivated FBS, penicillin G (100 U mL À1 ), streptomycin (100 mg L À1 ), and L-glutamine (2 mM), and they were incubated at 37 C in a humidied atmosphere containing 5% CO 2 . The cell viability was determined by adding 0.8 mL of CCK-8 to each well and incubated at 37 C for 4 h.
Then, the OD value was read at 450 nm using a Bio-Rad ELISA microplate reader.
To measure TNF-a production, cells were seeded in a 96-well plate at a density of 1.5 Â 10 6 cells per well in DMEM and incubated for 24 h. The cultures were prepared and stimulated with LPS (1 mg mL À1 ) in the presence or absence of LNE.
Thereaer, the cells were treated with 5, 20 and 50 mM concentrations of 1-23 respectively. The purity of compound 10 is 94.7%, the purity of compound 13 is 90.1%, the purity of other compounds range from 95.0% to 99.0% (see ESI †). Aer 24 h incubation, supernatant from the culture medium was harvested and used for measuring the level of TNF-a. TNFa were measured by using an ELISA kit.
